Infiuss Health

Infiuss Health

Private
Buffalo, New YorkHealthcare & Life Scienceshttps://infiuss.com

Last Round

Seed

Sep 29, 2022

Total Funding Raised

$3.33M

Momentum Score

50 /100

Company Overview

Infiuss Health is a health-tech company that has developed a decentralized, cloud-based software platform to facilitate clinical research and trials. The company's primary mission is to connect pharmaceutical companies, life sciences firms, and researchers with diverse patient populations, particularly in Africa, to accelerate research timelines and diversify participant cohorts. The platform offers end-to-end solutions for researchers, including patient recruitment, data collection and management, electronic consent, and virtual support. By providing access to high-quality, ethically sourced clinical data from real patients, Infiuss Health aims to make the clinical trial process faster and more cost-effective.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Patient Engagement, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Marketplace Commission, Data as a Service

AI Layer

Application

Keywords

decentralized clinical trialsDCTpatient recruitmentclinical trial diversityclinical research platformresearch marketplacebio-specimen sourcingreal-world dataRWDremote e-consentHealthTechCRO servicesData as a ServiceDaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Infiuss Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Infiuss Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 29, 2022
SeedOct 28, 2021
AcceleratorSep 1, 2021

Infiuss Health Investors

Notable investors and investment history

InvestorRounds
HealthCap AfricaSeed
Y CombinatorAccelerator
43NorthSeed
UM6P VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 20, 2026

    Launched DPT technology, reducing patient numbers by 38% and saving six months per trial.

Infiuss Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Infiuss Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Infiuss Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBuffalo, New York
Employee Range9
Year Founded2016
Last FundingSep 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.